A phase 1/PK study of Sunitinib with highly active antiretroviral therapy (HAART) in HIV+ patients with solid tumors: AIDS malignancy consortium study 061 by Deeken John F, Rudek Michelle A, Moore Page C, Aboulafia David, Sullivan Ryan, Gerecitano John, Cianfrocca Mary, Henry David, Ratner Lee, Dezube Bruce, Mosby Kimberly, Tibbals Melinda, Little Richard F, Ivy S P, Mitsuyasu Ronald T